TERMS & CONDITIONS:  This information is not intended to be medical advice. It is general health information and does not take into account your particular health status nor is it a substitute for personal medical care. If you are suffering from a medical condition or have any specific questions about any medical matter, consult your doctor or other professional healthcare provider. Northwest Women’s Health Care shall not be liable for any damages arising out of the use of the content herein.

Northwest Women’s Healthcare  |  75 Claremont Street  |  Suite A  |  (406)752-8282  |  Kalispell, MT 59901-3500

APPROVED USES

 

JUVÉDERM® XC injectable gel is injected in the areas of facial tissue where moderate to severe facial wrinkles and folds occur to temporarily add volume to skin, which may give appearance of a smoother surface. JUVÉDERM VOLUMA® XC injectible gel is for deep injection in the cheek area to correct age-related volume loss in adults over the age of 21.

 

IMPORTANT SAFETY INFORMATION

 

Are there any reasons why I should not receive JUVÉDERM® XC or JUVÉDERM VOLUMA® XC?

 

Do not use these products if you have a history of multiple sever allergies or severe allergic reactions (anaphylaxis), or if you are allergic to the proteins (gram-positive bacterial proteins) used to make the hyaluronic acid (HA) in these products. Do not use JUVÉDERM® XC orJUVÉDERM VOLUMA® XC if you are allergic to lidocaine.

 

What precautions should my doctor advise me about?

 

  • The safety of JUVÉDERM® XC and JUVÉDERM VOLUMA® XC injectible gels for use during pregnancy or in women who are breastfeeding has not been studied
  • The safety of JUVÉDERM® XC for use in patients under 18 years and JUVÉDERM VOLUMA® XC for patients under 35 years or over 65 years has not been studied
  • The safety and effectiveness of JUVÉDERM® XC for treatment of areas other than facial wrinkles and folds (such as lips) have not been established in clinical studies
  • The safety and effectiveness of JUVÉDERM VOLUMA® XC for treatment in areas other than the cheek area have not been established in clinical studies
  • The safety of JUVÉDERM® XC and JUVÉDERM VOLUMA® XC in patients with a history of excessive scarring (eg, hypertrophic scarring and keloid formations) and pigmentation disorders has not been studied, and use may result in additional scars or changes in pigmentation
  • The safety of JUVÉDERM VOLUMA® XC in patients with very thin skin in the cheek area and the safety of repeat treatments in patients has not been studied
  • There is a possible risk of inflammation at the treatment site if laser procedures and chemical peeling are performed after treatment
  • Patients who experience skin injury near the site of injection with these products may be at a higher risk for side effects
  • Tell your healthcare professional if you are on therapy used to decrease the body's immune response (immunosuppressive therapy). Use of these products may result in an increased risk of infection
  • Tell your healthcare professional if you are using medications that can prolong bleeding, such as asprin, ibuprofen, or other blood thinners, as this may result in increased bruising or bleeding at the injection site
  • Minimize strenuous exercise and exposure to extensive sun or heat within the first 24 hours following treatment with JUVÉDERM VOLUMA® XC

 

What are possible side effects?

 

For JUVÉDERM® XC, most side effects are mild or moderate in nature, and last 7 days or less. The most common side effects include temporary injection-site reactions such as: redness, pain/tenderness, firmness, swelling, lumps/bumps, bruising, itching, and discoloration.

For JUVÉDERM VOLUMA® XC, side effects are moderate (uncomfortable), and generally last 2 to 4 weeks. The most common side effects include temporary reactions at the treatment site such as tenderness, swelling, firmness, lumps/bumps, bruising, pain, redness, discoloration, and itching.

As with all skin-injection procedures, there is a risk of infection

I would also like our patient to link to brilliant distinctions program.